These findings corroborate earlier reports of cellular PLN downregulation in the context of heart failure.8 The dose-dependent efficacy of ASO-mediated PLN protein depletion, calculated as per cent reduction compared to vehicle-treated R14Δ/Δ mice, is shown in Supplementary material online, Table S4. This evidence concerns the gene PLN and heart failure.